Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 1195-1199, June 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Linder-Horowitz, M.
Right arrow Articles by Morris, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Linder-Horowitz, M.
Right arrow Articles by Morris, H. P.

Glutaminase Activities and Growth Rates of Rat Hepatomas1

Maria Linder-Horowitz, W. Eugene Knox and Harold P. Morris

Department of Biological Chemistry, Harvard Medical School, and the Cancer Research Institute, New England Deaconess Hospital, Boston, Massachusetts 02215, and the National Cancer Institute, NIH, Bethesda, Maryland 20014

For a series of transplantable rat hepatomas, the growth rate, as well as the type and quantity of glutaminase activity, was determined. The times for volume doubling of the hepatomas ranged from 3 to 29 days. All but the slowest growing of the hepatomas contained the kidney, rather than the liver, type of phosphate-dependent glutaminase, and for these tumors the same correlation was found between enzyme activity and growth rate that was found for a previous series of nonhepatic tumors.

1 This investigation was supported by USPHS Fellowship 1-F2-CA-17,695-01 from the National Cancer Institute (M. L-H.), USPHS Grant AM 00567, Research Career Award AM-K6-2018 from the NIH, United States Atomic Energy Commission Contract AT(30-1)-3779 with the New England Deaconess Hospital (W. E. K.), and USPHS Grant CA-10729 (H. P. M.).

Received 9/30/68. Accepted 2/ 5/69.




This article has been cited by other articles:


Home page
J. Cell Biol.Home page
M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
J. Cell Biol., October 3, 2007; 178(1): 93 - 105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Benlloch, S. Mena, P. Ferrer, E. Obrador, M. Asensi, J. A. Pellicer, J. Carretero, A. Ortega, and J. M. Estrela
Bcl-2 and Mn-SOD Antisense Oligodeoxynucleotides and a Glutamine-enriched Diet Facilitate Elimination of Highly Resistant B16 Melanoma Cells by Tumor Necrosis Factor-{alpha} and Chemotherapy
J. Biol. Chem., January 6, 2006; 281(1): 69 - 79.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.